Vazganush Gharibyan
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Genetics and Neurodevelopmental Disorders, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research, Cancer-related Molecular Pathways
Most-Cited Works
- → JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia(2005)370 cited
- → Phase II Study of Low-Dose Decitabine in Patients With Chronic Myelogenous Leukemia Resistant to Imatinib Mesylate(2005)287 cited
- → LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability(2007)265 cited
- → Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees(2011)206 cited
- → Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia(2007)135 cited
- → DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory(2012)130 cited
- → Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia(2011)115 cited
- → Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer(2016)108 cited
- → RIL , a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis(2007)72 cited
- → Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome(2016)69 cited